nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—KIT—skin epidermis—vulva cancer	0.0228	0.0228	CbGeAlD
Sorafenib—CDK7—uterine cervix—vulva cancer	0.0194	0.0194	CbGeAlD
Sorafenib—TAOK2—urethra—vulva cancer	0.0177	0.0177	CbGeAlD
Sorafenib—ZAK—uterine cervix—vulva cancer	0.0168	0.0168	CbGeAlD
Sorafenib—HIPK3—uterine cervix—vulva cancer	0.0164	0.0164	CbGeAlD
Sorafenib—TIE1—epithelium—vulva cancer	0.0155	0.0155	CbGeAlD
Sorafenib—ZAK—urethra—vulva cancer	0.0154	0.0154	CbGeAlD
Sorafenib—TIE1—uterine cervix—vulva cancer	0.0153	0.0153	CbGeAlD
Sorafenib—ZAK—mammalian vulva—vulva cancer	0.0147	0.0147	CbGeAlD
Sorafenib—TIE1—urethra—vulva cancer	0.0141	0.0141	CbGeAlD
Sorafenib—TAOK2—vagina—vulva cancer	0.013	0.013	CbGeAlD
Sorafenib—EPHX2—urethra—vulva cancer	0.0129	0.0129	CbGeAlD
Sorafenib—FLT4—epithelium—vulva cancer	0.0128	0.0128	CbGeAlD
Sorafenib—FGFR1—uterine cervix—vulva cancer	0.0125	0.0125	CbGeAlD
Sorafenib—EPHX2—mammalian vulva—vulva cancer	0.0123	0.0123	CbGeAlD
Sorafenib—MAP3K7—uterine cervix—vulva cancer	0.0118	0.0118	CbGeAlD
Sorafenib—MKNK2—epithelium—vulva cancer	0.0116	0.0116	CbGeAlD
Sorafenib—FGFR1—urethra—vulva cancer	0.0115	0.0115	CbGeAlD
Sorafenib—MKNK2—uterine cervix—vulva cancer	0.0115	0.0115	CbGeAlD
Sorafenib—ZAK—vagina—vulva cancer	0.0114	0.0114	CbGeAlD
Sorafenib—MKNK1—uterine cervix—vulva cancer	0.0113	0.0113	CbGeAlD
Sorafenib—RET—epithelium—vulva cancer	0.0113	0.0113	CbGeAlD
Sorafenib—HIPK3—vagina—vulva cancer	0.0111	0.0111	CbGeAlD
Sorafenib—FGFR1—mammalian vulva—vulva cancer	0.0109	0.0109	CbGeAlD
Sorafenib—MAP3K7—urethra—vulva cancer	0.0109	0.0109	CbGeAlD
Sorafenib—MKNK2—urethra—vulva cancer	0.0105	0.0105	CbGeAlD
Sorafenib—MKNK1—urethra—vulva cancer	0.0104	0.0104	CbGeAlD
Sorafenib—RALBP1—uterine cervix—vulva cancer	0.0104	0.0104	CbGeAlD
Sorafenib—MAP3K7—mammalian vulva—vulva cancer	0.0103	0.0103	CbGeAlD
Sorafenib—MKNK2—mammalian vulva—vulva cancer	0.01	0.01	CbGeAlD
Sorafenib—BRAF—vagina—vulva cancer	0.00996	0.00996	CbGeAlD
Sorafenib—FLT1—epithelium—vulva cancer	0.00993	0.00993	CbGeAlD
Sorafenib—MKNK1—mammalian vulva—vulva cancer	0.0099	0.0099	CbGeAlD
Sorafenib—RAF1—epithelium—vulva cancer	0.00987	0.00987	CbGeAlD
Sorafenib—FLT1—uterine cervix—vulva cancer	0.00985	0.00985	CbGeAlD
Sorafenib—RAF1—uterine cervix—vulva cancer	0.00979	0.00979	CbGeAlD
Sorafenib—EPHB6—uterine cervix—vulva cancer	0.00973	0.00973	CbGeAlD
Sorafenib—EPHX2—vagina—vulva cancer	0.00951	0.00951	CbGeAlD
Sorafenib—RALBP1—urethra—vulva cancer	0.00951	0.00951	CbGeAlD
Sorafenib—STK10—uterine cervix—vulva cancer	0.00932	0.00932	CbGeAlD
Sorafenib—RALBP1—mammalian vulva—vulva cancer	0.00906	0.00906	CbGeAlD
Sorafenib—FLT1—urethra—vulva cancer	0.00905	0.00905	CbGeAlD
Sorafenib—RAF1—urethra—vulva cancer	0.009	0.009	CbGeAlD
Sorafenib—EPHB6—urethra—vulva cancer	0.00894	0.00894	CbGeAlD
Sorafenib—MAPK11—lymph node—vulva cancer	0.00864	0.00864	CbGeAlD
Sorafenib—FLT1—mammalian vulva—vulva cancer	0.00861	0.00861	CbGeAlD
Sorafenib—RAF1—mammalian vulva—vulva cancer	0.00856	0.00856	CbGeAlD
Sorafenib—EPHB6—mammalian vulva—vulva cancer	0.00851	0.00851	CbGeAlD
Sorafenib—CDK7—lymph node—vulva cancer	0.0085	0.0085	CbGeAlD
Sorafenib—FGFR1—vagina—vulva cancer	0.00847	0.00847	CbGeAlD
Sorafenib—TAOK2—lymph node—vulva cancer	0.00843	0.00843	CbGeAlD
Sorafenib—KDR—epithelium—vulva cancer	0.00839	0.00839	CbGeAlD
Sorafenib—AURKC—lymph node—vulva cancer	0.00836	0.00836	CbGeAlD
Sorafenib—KDR—uterine cervix—vulva cancer	0.00832	0.00832	CbGeAlD
Sorafenib—MAP2K5—uterine cervix—vulva cancer	0.00832	0.00832	CbGeAlD
Sorafenib—STK10—mammalian vulva—vulva cancer	0.00815	0.00815	CbGeAlD
Sorafenib—CSF1R—uterine cervix—vulva cancer	0.00812	0.00812	CbGeAlD
Sorafenib—MAP3K7—vagina—vulva cancer	0.00801	0.00801	CbGeAlD
Sorafenib—MKNK2—vagina—vulva cancer	0.00777	0.00777	CbGeAlD
Sorafenib—MKNK1—vagina—vulva cancer	0.00767	0.00767	CbGeAlD
Sorafenib—KDR—urethra—vulva cancer	0.00765	0.00765	CbGeAlD
Sorafenib—MAP2K5—urethra—vulva cancer	0.00765	0.00765	CbGeAlD
Sorafenib—CSF1R—urethra—vulva cancer	0.00746	0.00746	CbGeAlD
Sorafenib—KIT—epithelium—vulva cancer	0.00744	0.00744	CbGeAlD
Sorafenib—KIT—uterine cervix—vulva cancer	0.00738	0.00738	CbGeAlD
Sorafenib—ZAK—lymph node—vulva cancer	0.00734	0.00734	CbGeAlD
Sorafenib—MAP2K5—mammalian vulva—vulva cancer	0.00728	0.00728	CbGeAlD
Sorafenib—KDR—mammalian vulva—vulva cancer	0.00728	0.00728	CbGeAlD
Sorafenib—PDGFRB—epithelium—vulva cancer	0.00727	0.00727	CbGeAlD
Sorafenib—PDGFRB—uterine cervix—vulva cancer	0.0072	0.0072	CbGeAlD
Sorafenib—HIPK3—lymph node—vulva cancer	0.00719	0.00719	CbGeAlD
Sorafenib—CSF1R—mammalian vulva—vulva cancer	0.00711	0.00711	CbGeAlD
Sorafenib—RALBP1—vagina—vulva cancer	0.00701	0.00701	CbGeAlD
Sorafenib—KIT—urethra—vulva cancer	0.00678	0.00678	CbGeAlD
Sorafenib—TIE1—lymph node—vulva cancer	0.00672	0.00672	CbGeAlD
Sorafenib—FLT1—vagina—vulva cancer	0.00667	0.00667	CbGeAlD
Sorafenib—RAF1—vagina—vulva cancer	0.00663	0.00663	CbGeAlD
Sorafenib—PDGFRB—urethra—vulva cancer	0.00662	0.00662	CbGeAlD
Sorafenib—EPHB6—vagina—vulva cancer	0.00659	0.00659	CbGeAlD
Sorafenib—KIT—mammalian vulva—vulva cancer	0.00645	0.00645	CbGeAlD
Sorafenib—BRAF—lymph node—vulva cancer	0.00644	0.00644	CbGeAlD
Sorafenib—STK10—vagina—vulva cancer	0.00632	0.00632	CbGeAlD
Sorafenib—PDGFRB—mammalian vulva—vulva cancer	0.0063	0.0063	CbGeAlD
Sorafenib—PDGFRA—vagina—vulva cancer	0.00625	0.00625	CbGeAlD
Sorafenib—EPHX2—lymph node—vulva cancer	0.00615	0.00615	CbGeAlD
Sorafenib—FLT3—lymph node—vulva cancer	0.00611	0.00611	CbGeAlD
Sorafenib—HTR2B—uterine cervix—vulva cancer	0.00571	0.00571	CbGeAlD
Sorafenib—KDR—vagina—vulva cancer	0.00564	0.00564	CbGeAlD
Sorafenib—MAP2K5—vagina—vulva cancer	0.00564	0.00564	CbGeAlD
Sorafenib—FLT4—lymph node—vulva cancer	0.00555	0.00555	CbGeAlD
Sorafenib—CSF1R—vagina—vulva cancer	0.0055	0.0055	CbGeAlD
Sorafenib—FGFR1—lymph node—vulva cancer	0.00548	0.00548	CbGeAlD
Sorafenib—MAP3K7—lymph node—vulva cancer	0.00518	0.00518	CbGeAlD
Sorafenib—MKNK2—lymph node—vulva cancer	0.00502	0.00502	CbGeAlD
Sorafenib—KIT—vagina—vulva cancer	0.005	0.005	CbGeAlD
Sorafenib—MKNK1—lymph node—vulva cancer	0.00496	0.00496	CbGeAlD
Sorafenib—RET—lymph node—vulva cancer	0.0049	0.0049	CbGeAlD
Sorafenib—PDGFRB—vagina—vulva cancer	0.00488	0.00488	CbGeAlD
Sorafenib—RALBP1—lymph node—vulva cancer	0.00454	0.00454	CbGeAlD
Sorafenib—FLT1—lymph node—vulva cancer	0.00432	0.00432	CbGeAlD
Sorafenib—RAF1—lymph node—vulva cancer	0.00429	0.00429	CbGeAlD
Sorafenib—EPHB6—lymph node—vulva cancer	0.00427	0.00427	CbGeAlD
Sorafenib—STK10—lymph node—vulva cancer	0.00408	0.00408	CbGeAlD
Sorafenib—ABCG2—uterine cervix—vulva cancer	0.00405	0.00405	CbGeAlD
Sorafenib—PDGFRA—lymph node—vulva cancer	0.00404	0.00404	CbGeAlD
Sorafenib—HTR2B—vagina—vulva cancer	0.00387	0.00387	CbGeAlD
Sorafenib—CYP3A5—uterine cervix—vulva cancer	0.00376	0.00376	CbGeAlD
Sorafenib—ABCG2—urethra—vulva cancer	0.00372	0.00372	CbGeAlD
Sorafenib—MAP2K5—lymph node—vulva cancer	0.00365	0.00365	CbGeAlD
Sorafenib—KDR—lymph node—vulva cancer	0.00365	0.00365	CbGeAlD
Sorafenib—CSF1R—lymph node—vulva cancer	0.00356	0.00356	CbGeAlD
Sorafenib—ABCG2—mammalian vulva—vulva cancer	0.00354	0.00354	CbGeAlD
Sorafenib—CYP2C19—vagina—vulva cancer	0.00323	0.00323	CbGeAlD
Sorafenib—KIT—lymph node—vulva cancer	0.00323	0.00323	CbGeAlD
Sorafenib—PDGFRB—lymph node—vulva cancer	0.00316	0.00316	CbGeAlD
Sorafenib—CYP2C8—vagina—vulva cancer	0.00282	0.00282	CbGeAlD
Sorafenib—ABCG2—vagina—vulva cancer	0.00274	0.00274	CbGeAlD
Sorafenib—CYP3A5—vagina—vulva cancer	0.00255	0.00255	CbGeAlD
Sorafenib—CYP2B6—vagina—vulva cancer	0.00253	0.00253	CbGeAlD
Sorafenib—ABCC4—lymph node—vulva cancer	0.00251	0.00251	CbGeAlD
Sorafenib—HTR2B—lymph node—vulva cancer	0.0025	0.0025	CbGeAlD
Sorafenib—ABCC2—lymph node—vulva cancer	0.00243	0.00243	CbGeAlD
Sorafenib—ABCB1—epithelium—vulva cancer	0.00201	0.00201	CbGeAlD
Sorafenib—ABCB1—uterine cervix—vulva cancer	0.002	0.002	CbGeAlD
Sorafenib—ABCB1—urethra—vulva cancer	0.00183	0.00183	CbGeAlD
Sorafenib—ABCG2—lymph node—vulva cancer	0.00177	0.00177	CbGeAlD
Sorafenib—ABCB1—mammalian vulva—vulva cancer	0.00175	0.00175	CbGeAlD
Sorafenib—ABCB1—vagina—vulva cancer	0.00135	0.00135	CbGeAlD
Sorafenib—ABCB1—lymph node—vulva cancer	0.000875	0.000875	CbGeAlD
